InsidersTradesSigma
Explore the complete record of transactions filed by Doody Kevin, Directeur Médical. Insider active across 1 companies, notably INVO Bioscience, Inc.. Cumulatively, 3 disclosures have been logged. Total volume traded: €158k. The latest transaction was disclosed on 1 June 2022 — Acquisition. Regulator: SEC (Form 4). All data is accessible without signup.
3 of 3 declarations
Kevin Doody serves as the Medical Director of INVO Bioscience, Inc. He oversees the medical and clinical aspects of the company. His expertise is crucial in ensuring compliance with medical standards and guiding research and development initiatives.